- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioPorto (BIOPOR)
The BioPorto share price today is 1.030 %REPORT_CURRENCY%, view CSE BIOPOR stock exchange data. Track the latest BioPorto share price with real-time updates on BIOPOR stock performance including market cap, day range, 52-week range and dividend yield. Access BIOPOR charts, earnings dates and analyst estimates to support your investment decisions.
Copenhagen
Currency in DKK
1.030
+0.058(+5.97%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.966
1.060
52 wk Range
0.839
1.620
BIOPOR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.9661.060
52 wk Range
0.8391.620
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BIOPOR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI); NGAL Test, a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine, EDTA plasma, or heparin plasma on automated clinical chemistry analyzers to diagnose acute kidney injury; and antibodies to develop diagnostic immunoassays within disease areas, including immunodeficiency, allergy, coagulation, diabetes, kidney, and cardiovascular disease. The company also provides ready-to-use enzyme-linked immunosorbent assay (ELISA) kits to quantify NGAL in urine, plasma, and serum; and generic Rapid Assay Device (gRAD) for custom lateral flow assays. BioPorto A/S was founded in 1917 and is based in Hellerup, Denmark.
Compare BIOPOR to Peers and Sector
Metrics to compare | BIOPOR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOPORPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.9x | 3.2x | −0.4x | |
PEG Ratio | −0.64 | 0.06 | 0.00 | |
Price/Book | 7.6x | 1.1x | 2.6x | |
Price / LTM Sales | 11.9x | 1.3x | 3.1x | |
Upside (Analyst Target) | 80.0% | 62.6% | 47.4% | |
Fair Value Upside | Unlock | 8.5% | 7.0% | Unlock |
Earnings
Latest Release
26-03-2026
EPS / Forecast
-0.02 / -0.04
Revenue / Forecast
11.58M / 16.5M
FAQ
What Is the BioPorto (BIOPOR) Share Price Today?
The BioPorto share price today is 1.030 DKK.
What is the current BioPorto (BIOPOR) share price and day range?
As of 27-04-2026, the BioPorto share price is 1.030 DKK, with a previous close of 0.972 DKK. The share price has ranged from 0.966 to 1.060 DKK today, while the 52-week range spans from 0.839 to 1.620 DKK.
What Is the BioPorto Market Cap?
As of today, BioPorto market cap is 509.960M.
What Is the BioPorto (BIOPOR) Share Price Target?
The average 12-month share price target for BioPorto is 1.750 DKK, with a high estimate of 1.75 DKK and a low estimate of 1.75 DKK. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +69.90% Upside potential.
What Is BioPorto's Earnings Per Share (TTM)?
The BioPorto EPS (TTM) is -0.153.
When Is the Next BioPorto Earnings Date?
BioPorto will release its next earnings report on 21-05-2026.
From a Technical Analysis Perspective, Is BIOPOR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does BioPorto Trade On?
BioPorto is listed and trades on the Copenhagen Stock Exchange.
What Is the Stock Symbol for BioPorto?
The stock symbol for BioPorto is "BIOPOR."
How Many Times Has BioPorto Stock Split?
BioPorto has split 3 times.
How Many Employees Does BioPorto Have?
BioPorto has 46 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.